Atlas Trials

Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema

Clinical trial NCT02329132 · COMPLETED

Trial details

NCT number
NCT02329132
Sponsor
Kagawa University
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetic Macular Edema
Start date
2015-11-01
Primary completion
2018-01-28
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.